Recently, germ-line mutations in several genes, such as TP53, RUNX1, GATA2 and CEBPA, have been found in families with an unexplained high risk of AML, suggesting a familial predisposition to develop AML [4,5,6,7,8]. This evidence concerns the gene CEBPA and acute myeloid leukemia.